MADISON, Miss.--(BUSINESS WIRE)--Cypress Pharmaceutical, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted final approval of the company’s abbreviated new drug application (ANDA) for Levetiracetam Oral Solution, 100 mg/mL.
